COMMUNIQUÉS West-GlobeNewswire

Caladrius Biosciences Doses First Patient with CLBS12 in Phase 2 Critical Limb Ischemia Trial in Japan

13/03/2018 - 13:00

BASKING RIDGE, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]

Rexahn Pharmaceuticals to Present at Two Upcoming Conferences

13/03/2018 - 13:00

B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium (CHIPS) on March 16 Oppenheimer 28th Annual Healthcare Conference on March 21 ROCKVILLE, Md., March 13, 2018 (GLOBE NEWSWIRE) -- Rexahn [...]

Biotricity Appoints Casey Shattuck as New VP of Sales to Spearhead Bioflux Launch

13/03/2018 - 13:00

REDWOOD CITY, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring [...]

MannKind Announces STAT Study Results Accepted for Presentation at American Diabetes Association’s 78th Scientific Sessions

13/03/2018 - 13:00

WESTLAKE VILLAGE, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD ) focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as [...]

Avinger Provides Update on U.S. Intellectual Property Portfolio

13/03/2018 - 13:00

REDWOOD CITY, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced three recent additions to its U.S [...]

RavenQuest Completes Final Tranche of Financing

13/03/2018 - 13:00

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS VANCOUVER, British Columbia, March [...]

AIT Therapeutics Announces Year End 2017 Financial Results Conference Call and Webcast

13/03/2018 - 13:00

Call Scheduled for Monday, March 19, 2018 at 4:30pm Eastern Time. NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled [...]

Annual General Meeting 2018 – GN Store Nord A/S

13/03/2018 - 12:48

Today, GN Store Nord A/S held its annual general meeting in accordance with the agenda announced on February 19, 2018. The report by the board of directors was adopted, and both the Annual Report 2017 and the proposal [...]

Checkpoint Therapeutics to Participate in March Investor Conferences

13/03/2018 - 12:45

NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT ), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]

Mustang Bio to Present at March Investor Conferences

13/03/2018 - 12:45

NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]

Fortress Biotech to Present at Oppenheimer’s 28th Annual Healthcare Conference

13/03/2018 - 12:45

NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO ) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]

Fluidigm Announces Exchange of Convertible Notes

13/03/2018 - 12:45

SOUTH SAN FRANCISCO, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced that it has entered into separate privately negotiated transactions to exchange approximately $25.0 [...]

Innovate Biopharmaceuticals appoints June Almenoff, M.D., Ph.D. as Chief Operating Officer and Chief Medical Officer

13/03/2018 - 12:32

Dr. Almenoff brings more than 20 years of pharmaceutical executive experience from GlaxoSmithKline and from Furiex Pharmaceuticals, where as President and Chief Medical Officer, she oversaw the development of Viberzi [...]

OpGen Announces Collaborator in Verification Study for Acuitas® Test

13/03/2018 - 12:30

GAITHERSBURG, Md., March 13, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) announced today that it is collaborating with Beth Israel Deaconess Medical Center (BIDMC) in Boston on a verification study for OpGen’s [...]

Intra-Cellular Therapies Announces Positive Pre-NDA Meeting with FDA for Lumateperone for the Treatment of Schizophrenia

13/03/2018 - 12:30

NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]

Epizyme Reports Fourth Quarter and Full Year 2017 Operating Results and 2018 Milestones

13/03/2018 - 12:30

First Tazemetostat NDA Submission for Epithelioid Sarcoma Targeted for Fourth Quarter of 2018; Second Tazemetostat NDA Submission for Follicular Lymphoma Targeted for 2019 Multiple Phase 2 Study Data Readouts Planned in [...]

Pacific Biosciences Announces Issuance of U.S. Patent for Concatemer Sequencing

13/03/2018 - 12:30

MENLO PARK, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB ), the leader in long-read, high-resolution sequencing, today announced that the U.S. Patent and Trademark [...]

Actinium Announces FDA Clearance of IND For Phase 1 trial of Actimab-A in Combination with CLAG-M for Patients with Relapsed or Refractory AML

13/03/2018 - 12:30

Clinical trial to be conducted by the Medical College of Wisconsin as an investigator initiated trial led by Dr. Sameem Abedin in collaboration with Dr. Ehab Atallah Combination trial expands addressable patient [...]

Summit's Infectious Diseases Technology Platform Yields Novel Antibiotics with Potential in Global Fight Against Gonorrhoea

13/03/2018 - 12:01

Summit Therapeutics plc ("Summit" or the "Company") Summit's Infectious Diseases Technology Platform Yields Novel Antibiotics with Potential in Global Fight Against Gonorrhoea Oxford, UK, and Cambridge, MA, US, 13 March [...]